Medical Properties Trust (MPW) Stock Forecast, Price & News

11 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Medical Properties Trust in the last year. There are currently 7 hold ratings, 3 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" MPW shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in MPW, but not buy additional shares or sell existing shares.
View MPW analyst ratings or view top-rated stocks.

11 Wall Street analysts have issued 12 month target prices for Medical Properties Trust's stock. Their MPW share price forecasts range from $9.00 to $18.00. On average, they expect the company's share price to reach $13.23 in the next year. This suggests a possible upside of 67.1% from the stock's current price.
View analysts price targets for MPW or view top-rated stocks among Wall Street analysts.

Medical Properties Trust's stock was trading at $11.14 at the beginning of the year. Since then, MPW stock has decreased by 28.9% and is now trading at $7.92.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Wednesday, August 2nd 2023.
View our MPW earnings forecast.

Medical Properties Trust, Inc. (NYSE:MPW) posted its quarterly earnings data on Thursday, April, 28th. The real estate investment trust reported $1.05 EPS for the quarter, beating the consensus estimate of $0.47 by $0.58. The real estate investment trust had revenue of $409.80 million for the quarter, compared to analysts' expectations of $413.31 million. Medical Properties Trust had a trailing twelve-month return on equity of 3.50% and a net margin of 20.48%. The company's revenue for the quarter was up 13.0% compared to the same quarter last year. During the same period in the previous year, the business earned $0.42 earnings per share.

Medical Properties Trust declared a quarterly dividend on Thursday, April 27th. Investors of record on Thursday, June 15th will be given a dividend of $0.29 per share on Thursday, July 13th. This represents a $1.16 dividend on an annualized basis and a yield of 14.65%. The ex-dividend date is Wednesday, June 14th.
Read our dividend analysis for MPW.

ETFs with the largest weight of Medical Properties Trust (NYSE:MPW) stock in their portfolio include Invesco KBW Premium Yield Equity REIT ETF (KBWY), ALPS REIT Dividend Dogs ETF (RDOG), RiverFront Dynamic US Dividend Advantage ETF (RFDA), iShares Residential and Multisector Real Estate ETF (REZ), BNY Mellon Global Infrastructure Income ETF (BKGI), Franklin U.S. Low Volatility High Dividend Index ETF (LVHD), Virtus Real Asset Income ETF (VRAI) and Hoya Capital High Dividend Yield ETF (RIET).

Medical Properties Trust (NYSE:MPW) pays an annual dividend of $1.16 per share and currently has a dividend yield of 15.09%. MPW has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The company has been increasing its dividend for 8 consecutive years, indicating the company has a new, but growing committment to grow its dividend. The dividend payout ratio is 232.00%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on earnings estimates, MPW will have a dividend payout ratio of 73.89% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for MPW.

Medical Properties Trust issued an update on its FY 2023 earnings guidance on Thursday, April, 27th. The company provided EPS guidance of $1.50-$1.61 for the period, compared to the consensus earnings per share estimate of $1.59. The company issued revenue guidance of -.

Based on aggregate information from My MarketBeat watchlists, some companies that other Medical Properties Trust investors own include AT&T (T), Verizon Communications (VZ), Energy Transfer (ET), Enterprise Products Partners (EPD), Omega Healthcare Investors (OHI), New Residential Investment (NRZ), Cisco Systems (CSCO), Pfizer (PFE), AbbVie (ABBV) and Intel (INTC).

Medical Properties Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "MPW."

Medical Properties Trust's stock is owned by a number of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.16%), State Street Corp (6.09%), Bank of New York Mellon Corp (2.11%), Geode Capital Management LLC (1.92%), Dimensional Fund Advisors LP (1.42%) and Principal Financial Group Inc. (1.30%). Insiders that own company stock include Edward K Aldag Jr, Emmett E Mclean, James Kevin Hanna, Michael G Stewart and R Steven Hamner.
View institutional ownership trends.

Shares of MPW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of MPW stock can currently be purchased for approximately $7.92.

Medical Properties Trust (NYSE:MPW) has a market capitalization of $4.74 billion and generates $1.48 billion in revenue each year. The real estate investment trust earns $902.60 million in net income (profit) each year or $0.50 on an earnings per share basis.

The company employs 112 workers across the globe.

Medical Properties Trust's mailing address is 1000 URBAN CENTER DRIVE SUITE 501, BIRMINGHAM AL, 35242. The official website for the company is www.medicalpropertiestrust.com. The real estate investment trust can be reached via phone at (205) 969-3755, via email at tberryman@medicalpropertiestrust.com, or via fax at 205-969-3756.